EP3195873
Ný ónæmismeðferð gegn fjölmörgum æxlum, þar á meðal krabbameini í meltingarfærum og maga
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.3.2011EP published:
24.7.2019EP application number:
17157398.3
EP translation filed:
16.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
14.3.2031Expiry date:
14.3.2024
Title:
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER
Timeline
Today
15.3.2011EP application
24.7.2019EP Publication
16.10.2019Translation submitted
15.11.2019Registration published
14.3.2024Expires
Owner
Name:
Immatics biotechnologies GmbHAddress:
Paul-Ehrlich-Strasse 15, 72076, Tübingen, DE
Inventor
Name:
Weinschenk, ToniAddress:
Aichwald, DE
Name:
Fritsche, JensAddress:
Dusslingen, DE
Name:
Walter, SteffenAddress:
Houston, TX, US
Name:
Lewandrowski, PeterAddress:
Tübingen-Hirschau, DE
Name:
Singh, HarpreetAddress:
Munich, DE
Agent
Name:
Boehmert & BoehmertAddress:
Pettenkoferstrasse 20-22, DE
Priority
Number:
315704 PDate:
19.3.2010Country:
US
Number:
201004551Date:
19.3.2010Country:
GB
Classification
Categories:
A61K 38/17, A61K 39/00, C07K 7/06, C07K 7/08, G01N 33/50, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 19.3.2020
Expires: 14.3.2021
Payer: Patice ehf.
Number: 11
Paid: 18.3.2021
Expires: 14.3.2022
Payer: Patice ehf.
Number: 12
Paid: 17.3.2022
Expires: 14.3.2023
Payer: Patice ehf.
Number: 13
Paid: 17.3.2023
Expires: 14.3.2024
Payer: Árnason Faktor ehf.